1Dursun A,Akyurek N,Gunel N,et al.Prognostic implication of nm23-H1 expression in colorectal carcinomas[J].Pathology,2002,34(5):427-432.
2Dusonchet L,Corsale S,Migliavacca M,et al.Nm23-H1 expression does not predict clinical survival in colorectal cancer patients[J].Oncology Reports,2003,10(5):1 257-1 263.
3Muneyuki T,Watanabe M,Yamanaka M,et al.KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer[J].Anticancer Research,2001,21(5):3 581-3 587.
5Naokuni Tatsumoto,Eiso Hiyama,Yoshiaki Murakami,et al.High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer[J].Clinical cancer research,2000,6:2 696-2 701.
6M.Colombino A,Cossu MF,Dedola,et al.Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma[J].Annals of oncology,2002,13:1 447-1 453.
7Seok-Byung Lim,Seung-Yong Jeong,Min Ro Lee,et al.Prognostic significance of microsatellite instability in sporadic colorectal cancer[J].International journal of colorectal disease,2004,19:533-537.
8Riad Haddad,Robert T,Ogilvie,et al.Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases[J].Annnal of surgical oncology 2004,11:977-982.
9Vizoso FJ,Fernandez JC,Corte MD,et al.Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer.Journal of cancer research and clinical oncology,2004,130(11):679-686.
10Yukawa N,Yoshikawa T,Sugimasa M,et al.Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma[J].The British Journal of Surgery,2001,88:1 596-1 601.
二级参考文献12
1[10]Tagawa K, Arihiro K, Takeshima Y, et al. Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma[J]. Jpn J Cancer Res,1999, 90(9):970-976.
2[11]Miyazaki T, Kato H, Shitara Y, et al. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma[J]. Cancer, 2000, 89(5): 955-962.
3[1]Uzawa K, Ono K, Suzuki H, et al. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis[J]. Clin Cancer Res,2002,8(3):828-835.
4[2]Liu F S, Chen J T, Dong J T, et al. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma[J]. Am J Pathol,2001,159(5):1629-1634.
5[3]Schindl M,Birner P,Breitenecker G,et al. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer[J]. Gynecol Oncol, 2001, 83(2): 244-248.
6[4]Geradts J, Maynard R, Birrer M J, et al. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms[J]. Am J Pathol,1999, 154 (6): 1665-1671.
7[5]Dong J T, Lamb P W, Rinker-Schaeffer C W, et al. KAI1,a metastasis suppressor gene for prostate cancer on human chromosome 11p11. 2[J]. Scince, 1995, 268(5212): 884-886.
8[6]Maurer C A, Graber H U, Friess H, et al. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases[J]. Surgery, 1999,126(5):869-880.
9[7]Muneyuki T,Watanabe M, Yamanaka M, et al. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer[J]. Anticancer Res, 2001,21 (5): 3581-3587.
10[8]Lombardi D P, Geradts J, Foley J F, et al. Loss of KAI1 expression in the progression of colorectal cancer[J]. Cancer Res,1999,59 (22): 5724 -5731.
